Realising the true benefits of risk management with Brian Barnes

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Brian Barnes, Director of Risk Management Strategy at BioNTech, to explore the human and strategic dimensions of risk-based quality management (RBQM).

Drawing from his rich experience across CROs, technology vendors, and now a sponsor organisation, Brian shares how his role as a “risk assessment facilitator” reflects a broader cultural shift: developing a company-wide risk-focused mindset and moving risk management upstream into study design and operational planning.

Sylvain and Brian talk about building risk frameworks from the ground up, demonstrating return on investment for RBQM and confronting resistance and misconceptions. Brian offers practical insight into why RBQM is less about the tools and more about people, collaboration, and culture.

Tune in to discover what “good” risk management looks like and how to make it stick – across teams, trials, and organisations.

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

From our operations leaders David Im & Marci Mogg

When speaking with David and Marci, we realize how naturally their perspectives complement each other, from their user focus to how they influence product design.

The must-haves for today’s eClinical vendors

What sets CRScube and Mednet apart is their ability to support global studies with local understanding, regional expertise, and a broad, complementary technology portfolio.

cubeCDMS is now rated #1 EDC solution by users on G2

In clinical research, where data integrity, compliance, speed, and usability all matter, having an EDC system that genuinely works makes a huge difference.